Melatonin inhibits MLL-rearranged leukemia via RBFOX3/hTERT and NF-κB/COX-2 signaling pathways.
Tang YL, Sun X, Huang LB, Liu XJ, Qin G, Wang LN, Zhang XL, Ke ZY, Luo JS, Liang C, Peng CJ, Tang WY, Li Y, Huang W, Luo XQ, Deng W.
Tang YL, et al. Among authors: zhang xl.
Cancer Lett. 2019 Feb 28;443:167-178. doi: 10.1016/j.canlet.2018.11.037. Epub 2018 Dec 11.
Cancer Lett. 2019.
PMID: 30550850